ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Genome Diagnostics Ltd

Genome Diagnostics Ltd is an active company incorporated on 31 January 2020 with the registered office located in Belfast, County Down. Genome Diagnostics Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
NI667396
Private limited company
Northern Ireland Company
Age
5 years
Incorporated 31 January 2020
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 20 February 2025 (8 months ago)
Next confirmation dated 20 February 2026
Due by 6 March 2026 (4 months remaining)
Last change occurred 1 year 8 months ago
Accounts
Submitted
For period 1 Feb31 Jan 2024 (12 months)
Accounts type is Micro Entity
Next accounts for period 31 January 2025
Was due on 31 October 2025 (1 day ago)
Address
C/O Qubis Ltd
63 University Road
Belfast
BT7 1NF
Northern Ireland
Same address since incorporation
Telephone
07972 056063
Email
Unreported
People
Officers
4
Shareholders
9
Controllers (PSC)
1
Director • British • Lives in UK • Born in Sep 1984
Director • Enterprise Manager • British • Lives in Northern Ireland • Born in May 1981
Director • Research Scientist • British • Lives in Northern Ireland • Born in Apr 1967
Director • Chief Executive • British • Lives in Northern Ireland • Born in Apr 1995
Qubis Ltd
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Mologic Ltd
Mark Andrew Street-Docherty is a mutual person.
Active
Street-Docherty Properties Limited
Mark Andrew Street-Docherty is a mutual person.
Active
Absolute Logic Limited
Mark Andrew Street-Docherty is a mutual person.
Active
Phasora Ltd
Anne Elizabeth Dornan is a mutual person.
Active
Amply Discovery Limited
Anne Elizabeth Dornan is a mutual person.
Active
Generatr Limited
Anne Elizabeth Dornan is a mutual person.
Active
Rosa Biotech Limited
Mark Andrew Street-Docherty is a mutual person.
Dissolved
Brands
GenoME Diagnostics
GenoME Diagnostics Ltd is a spin-out of Queen’s University Belfast, founded from scientific research at the Patrick G Johnston Centre for Cancer Research.
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Jan 2024
For period 31 Jan31 Jan 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
6
Increased by 2 (+50%)
Total Assets
£1.14M
Increased by £849.49K (+293%)
Total Liabilities
-£36.6K
Decreased by £96.74K (-73%)
Net Assets
£1.1M
Increased by £946.23K (+605%)
Debt Ratio (%)
3%
Decreased by 42.8% (-93%)
Latest Activity
Confirmation Submitted
8 Months Ago on 4 Mar 2025
Micro Accounts Submitted
1 Year Ago on 25 Oct 2024
Confirmation Submitted
1 Year 8 Months Ago on 5 Mar 2024
Micro Accounts Submitted
2 Years Ago on 31 Oct 2023
Confirmation Submitted
2 Years 8 Months Ago on 20 Feb 2023
Micro Accounts Submitted
3 Years Ago on 31 Oct 2022
Dr Mark Andrew Street-Docherty Appointed
3 Years Ago on 1 Jun 2022
Dr Shannon Beattie Appointed
3 Years Ago on 1 Jun 2022
Confirmation Submitted
3 Years Ago on 21 Mar 2022
Micro Accounts Submitted
4 Years Ago on 28 Oct 2021
Get Credit Report
Discover Genome Diagnostics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 20 February 2025 with no updates
Submitted on 4 Mar 2025
Micro company accounts made up to 31 January 2024
Submitted on 25 Oct 2024
Confirmation statement made on 20 February 2024 with updates
Submitted on 5 Mar 2024
Micro company accounts made up to 31 January 2023
Submitted on 31 Oct 2023
Resolutions
Submitted on 13 Sep 2023
Statement of capital following an allotment of shares on 17 May 2023
Submitted on 22 May 2023
Statement of capital following an allotment of shares on 21 April 2023
Submitted on 24 Apr 2023
Statement of capital following an allotment of shares on 5 April 2023
Submitted on 17 Apr 2023
Statement of capital following an allotment of shares on 7 March 2023
Submitted on 21 Mar 2023
Confirmation statement made on 20 February 2023 with updates
Submitted on 20 Feb 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year